Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 3
2014 3
2015 3
2016 3
2017 5
2018 5
2019 3
2020 4
2021 3
2022 4
2023 2
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
Response to "Letter to the Editor Regarding 'Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab vs. Dupilumab in Moderate to Severe Atopic Dermatitis'".
Rand K, Ramos-Goñi JM, Akmaz B, Solé-Feu L, Armario-Hita JC. Rand K, et al. Among authors: ramos goni jm. Dermatol Ther (Heidelb). 2024 Mar;14(3):823-827. doi: 10.1007/s13555-024-01107-1. Epub 2024 Mar 5. Dermatol Ther (Heidelb). 2024. PMID: 38438784 Free PMC article. No abstract available.
Correction to: Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab versus Dupilumab in Moderate-to-Severe Atopic Dermatitis.
Rand K, Ramos-Goñi JM, Akmaz B, Solé-Feu L, Armario-Hita JC. Rand K, et al. Among authors: ramos goni jm. Dermatol Ther (Heidelb). 2024 Jan;14(1):183-185. doi: 10.1007/s13555-023-01076-x. Dermatol Ther (Heidelb). 2024. PMID: 38245639 Free PMC article. No abstract available.
Correction to: EQ-5D-Y Value Set for Germany.
Kreimeier S, Mott D, Ludwig K, Greiner W; IMPACT HTA HRQoL Group. Kreimeier S, et al. Pharmacoeconomics. 2022 Dec;40(Suppl 2):231. doi: 10.1007/s40273-022-01206-x. Pharmacoeconomics. 2022. PMID: 36229568 Free PMC article. No abstract available.
Health-Related Quality of Life and Perceived Burden of Informal Caregivers of Patients with Rare Diseases in Selected European Countries.
Valcárcel-Nazco C, Ramallo-Fariña Y, Linertová R, Ramos-Goñi JM, García-Pérez L, Serrano-Aguilar P. Valcárcel-Nazco C, et al. Among authors: ramos goni jm. Int J Environ Res Public Health. 2022 Jul 5;19(13):8208. doi: 10.3390/ijerph19138208. Int J Environ Res Public Health. 2022. PMID: 35805867 Free PMC article.
EQ-5D-Y Value Set for Germany.
Kreimeier S, Mott D, Ludwig K, Greiner W; IMPACT HTA HRQoL Group. Kreimeier S, et al. Pharmacoeconomics. 2022 Dec;40(Suppl 2):217-229. doi: 10.1007/s40273-022-01143-9. Epub 2022 May 23. Pharmacoeconomics. 2022. PMID: 35604633 Free PMC article.
The Development and Strengthening of Methods for Valuing EQ-5D-5L – An Overview.
Stolk E, Ramos-Goñi JM, Ludwig K, Oppe M, Norman R. Stolk E, et al. Among authors: ramos goni jm. 2022 Mar 24. In: Devlin N, Roudijk B, Ludwig K, editors. Value Sets for EQ-5D-5L: A Compendium, Comparative Review & User Guide [Internet]. Cham (CH): Springer; 2022. Chapter 2. 2022 Mar 24. In: Devlin N, Roudijk B, Ludwig K, editors. Value Sets for EQ-5D-5L: A Compendium, Comparative Review & User Guide [Internet]. Cham (CH): Springer; 2022. Chapter 2. PMID: 36810038 Free Books & Documents. Review.
EQ-5D-Y Value Set for Slovenia.
Prevolnik Rupel V, Ogorevc M; IMPACT HTA HRQoL Group. Prevolnik Rupel V, et al. Pharmacoeconomics. 2021 Apr;39(4):463-471. doi: 10.1007/s40273-020-00994-4. Epub 2021 Feb 10. Pharmacoeconomics. 2021. PMID: 33565048 Free PMC article.
36 results